Not Available
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
---|---|---|---|---|---|---|
T Max | 4.5 | h | 4-5 | h | Oral single dose; | DRUGBANK |
Metabolic | 76.0 | % | 76 | % | DRUGBANK | |
Clearance | 19.6 | L/h | 19.6 | L/h | apparent clearance; | DRUGBANK | Clearance | 52.4 | L/h | 52.4 | L/h | apparent clearance; | DRUGBANK |
Volume of Distribution | 551.0 | L | 551.0 | L | Apparent volume of distribution; | DRUGBANK | Volume of Distribution | 81.1 | L | 81.1 | L | Apparent volume of distribution; | DRUGBANK |
Half-life | 20.0 | h | 20 | h | elimination half-life; | DRUGBANK | Half-life | 40.0 | h | 40 | h | Active metabolite; | DRUGBANK |
Eliminate Route | 83.0 | % | 83 | % | Faeces excretion; Single dose; | DRUGBANK | Eliminate Route | 3.0 | % | 3 | % | Urinary excretion; Single dose; | DRUGBANK |
Protein Binding | 99.0 | % | >99 | % | plasma proteins; | DRUGBANK |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Frequency | Brand Name | Component | Reference |
---|---|---|---|---|---|---|---|---|---|
Max dose for children | 600.0 | mg/day | 600 | mg/day | PO, oral | Rozlytrek | entrectinib | PDR | |
Max dose for children | 500.0 | mg/day | 500 | mg/day | PO, oral | Rozlytrek | entrectinib | PDR | |
Max dose for children | 400.0 | mg/day | 400 | mg/day | PO, oral | Rozlytrek | entrectinib | PDR | |
Max dose for adolescents | 600.0 | mg/day | 600 | mg/day | PO, oral | Rozlytrek | entrectinib | PDR | |
Max dose for adolescents | 500.0 | mg/day | 500 | mg/day | PO, oral | Rozlytrek | entrectinib | PDR | |
Max dose for adolescents | 400.0 | mg/day | 400 | mg/day | PO, oral | Rozlytrek | entrectinib | PDR | |
Max dose for adults | 600.0 | mg/day | 600 | mg/day | PO, oral | qd | Rozlytrek | entrectinib | PDR |
Max dose for geriatric | 600.0 | mg/day | 600 | mg/day | PO, oral | qd | Rozlytrek | entrectinib | PDR |